Ono Pharma Foundation is located in New York, NY. The organization was established in 2017. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ono Pharma Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 01/2022, Ono Pharma Foundation generated $361.7k in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 15.7% each year . All expenses for the organization totaled $3.4m during the year ending 01/2022. You can explore the organizations financials more deeply in the financial statements section below.
Since 2019, Ono Pharma Foundation has awarded 107 individual grants totaling $42,081,027. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE PURPOSE OF THE ONO PHARMA BREAKTHROUGH SCIENCE INITIATIVE AWARDS PROGRAM IS TO SUPPORT SCIENTIST PRINCIPAL INVESTIGATORS WITH CREATIVE IDEAS IN SELECTED SCIENTIFIC RESEARCH FIELDS WITH THE MISSION OF SEEKING DISCOVERIES/SOLUTIONS AND DEVELOPMENT OF HIGH IMPACT SCIENCE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Tetsuya Sugiyama President | 20 | $0 | |
Hiroshi Ochiai Vice President | 10 | $0 | |
Tomoyuki Bando Treasurer | 2 | $0 | |
Masaya Kokubo Secretary | 5 | $0 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $361,696 |
Interest on Savings | $0 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $361,696 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $0 |
Depreciation | $1,302 |
Occupancy | $0 |
Travel, conferences, and meetings | $0 |
Printing and publications | $0 |
Other expenses | $24,534 |
Total operating and administrative expenses | $230,807 |
Contributions, gifts, grants paid | $3,132,076 |
Total expenses and disbursements | $3,362,883 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $3,010,565 |
Savings and temporary cash investments | $0 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $13,568,567 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $16,667 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $14,332 |
Total assets | $16,610,131 |
Accounts payable and accrued expenses | $847 |
Grants payable | $5,913,726 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $31,390 |
Total liabilities | $5,945,963 |
Over the last fiscal year, Ono Pharma Foundation has awarded $10,743,728 in support to 31 organizations.
Grant Recipient | Amount |
---|---|
SALK INSTITUTE FOR BIOLOGICAL STUDIES DR ALAN SAGHATELIAN PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $839,491 |
STANFORD UNIVERSITY DR ELIZABETH SATTELY PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $839,491 |
BROAD INSTITUTE OF HARVARD & MIT DR XIAO WANG PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $839,491 |
UNIVERSITY OF CHICAGO YAMUNA KRISHNAN PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $508,311 |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO JASON K SELLO PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $508,311 |
BOSTON COLLEGE ERANTHIE WEERAPANA PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $508,311 |
Organization Name | Assets | Revenue |
---|---|---|
John R Oishei Foundation Buffalo, NY | $294,151,477 | $18,357,929 |
Lor Foundation Inc West Chester, PA | $352,392,197 | $12,888,892 |
Grable Foundation Pittsburgh, PA | $386,701,292 | $35,946,563 |
Connelly Foundation West Conshohocken, PA | $387,913,026 | $27,891,431 |
American Express Foundation New York, NY | $66,234,265 | $62,922,703 |
Essel Foundation Inc Purchase, NY | $100,106,056 | $12,292,478 |
Beth And Ravenel Curry Foundation New York, NY | $0 | $44,744,046 |
Kz Family Foundation New York, NY | $10,936,301 | $30,139,672 |
The Freeman Foundation P-01644-00-7 New York, NY | $343,405,683 | $35,941,951 |
Hearst Foundation Inc New York, NY | $439,249,947 | $42,040,987 |
Tansy Charitable Foundation New York, NY | $325,076,608 | $77,631,295 |
Gordon & Llura Gund Foundation Princeton, NJ | $18,024,465 | $6,191,436 |